A pilot study on the effectiveness of a language‐specific (Chinese) pulmonary rehabilitation programme for individuals with chronic pulmonary disease: a 2‐year prospective cohort study in Sydney, Australia

Author:

Auyeung Titus12ORCID,Jiang Osborn3,Taylor Mitchell4,Chang Vicky1,Kwan Benjamin15ORCID

Affiliation:

1. Department of Respiratory Medicine The Sutherland Hospital, South Eastern Sydney Local Health District Sydney New South Wales Australia

2. South Eastern Sydney Clinical School The University of New South Wales Sydney New South Wales Australia

3. Prince of Wales Hospital South Eastern Sydney Local Health District Sydney New South Wales Australia

4. Functional Lungs Physiotherapy Sydney New South Wales Australia

5. St. Vincent's Clinical School The University of New South Wales Sydney New South Wales Australia

Abstract

AbstractBackground and AimsPulmonary rehabilitation (PR) improves dyspnoea, fatigue and healthcare‐related quality of life (QoL) in patients with chronic lung disease (CLD). Non‐English‐speaking background (NESB) patients face language and cultural barriers that hinder their access to PR programmes, contributing to health disparities. Our trial aimed to demonstrate the effectiveness and feasibility of a Chinese language‐specific PR programme on lung function, functional exercise capacity and QoL measures.MethodsA prospective cohort study was conducted over a 2‐year period. Participants were enrolled in an 8‐week PR programme with biweekly sessions conducted by Chinese‐speaking physiotherapists. Baseline and post‐rehabilitation testing included pulmonary function testing, 6‐min walk test (6MWT), St. George Respiratory Questionnaire (SGQR) and Short Form Health Survey (SF‐36).ResultsWe enrolled 76 patients (58% male) with a median age of 77 years (interquartile range (IQR) 68–81) and achieved a completion rate of 86.8% (n = 66). CLD included chronic obstructive pulmonary disease (42%), asthma (15%) and interstitial lung disease (3%). Baseline median forced expiratory volume in 1 s (FEV1) was 1.63 L (IQR 1.17–2.05), and the median 6MWT was 282 m (IQR 232–332). Post‐intervention median 6MWT increased to 332 m (IQR 290–390), and the median FEV1 was 1.99 L (IQR 1.3–2.1). Both QoL measures (SGQR and SF‐36) showed significant improvement after intervention (P < 0.05).ConclusionOur study demonstrates that a language‐specific PR programme is feasible, improving outcomes in NESB patients with CLD. The improvement in 6MWT and QoL measures was comparable to English‐based programmes. Ensuring equal access to healthcare programmes, regardless of cultural background or language barriers, is crucial in promoting health equity.

Funder

AstraZeneca Australia

Publisher

Wiley

Subject

Internal Medicine

Reference33 articles.

1. Australian Bureau of Statistics. National Health Survey: First Results Methodology [Internet] 2020‐2021 [updated 2022 March; cited 2022 Nov 10]. Available from URL:https://www.abs.gov.au/methodologies/national-health-survey-first-results-methodology/2020-21

2. Global Initiative for Chronic Obstructive Lung Disease.Global Strategy for the Diagnosis Management and Prevention of Chronic Obstructive Pulmonary Disease [Internet]; 2022 [updated 2022 Jan; cited 2022 Sept 8]. Available from URL:https://goldcopdorg/wp-content/uploads/2022/12/GOLD-2023-ver-11-2Dec2022_WMVpdf

3. A Comparison of Symptom Prevalence in Far Advanced Cancer, AIDS, Heart Disease, Chronic Obstructive Pulmonary Disease and Renal Disease

4. National Heart Lung and Blood Institute.Pulmonary Rehabilitation [Internet]. National Institutes of Health U.S. Department of Health and Human Services; [updated 2022 March; cited 2022 Sept 8]. Available from URL:https://www.nhlbi.nih.gov/health/pulmonary-rehabilitation

5. Lung Foundation Australia.Pulmonary Rehabilitation [Internet]; 2018 [updated 2018 September; cited 2019 Oct 9]. Available from URL:https://lungfoundation.com.au/wp-content/uploads/2018/09/Factsheet-Pulmonary-rehabilitation-Sep2018.pdf

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3